# Editas Medicine, Inc.: Form 8-K, filed Feb 19, 2016

- Company: [Editas Medicine, Inc.](/companies/edit.md) (CIK 1650664)
- Form: 8-K
- Filed: 2016-02-19
- Accepted by EDGAR: Feb 19, 2016, 16:15 ET
- Period: 2016-02-12
- Accession: 0001104659-16-098504
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1650664/000110465916098504/a16-4765_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650664/000110465916098504/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650664/000110465916098504/a16-4765_18k.htm

Filed Feb 19, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-098504. Last ingested by Listed: Nov 14, 2026, 21:28 ET. No prices; not investment advice.
